This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.
Recombinant Influenza A Virus Hemagglutinin (h9), His
Product Overview
BioVenic's Recombinant Influenza A Virus Hemagglutinin (h9), His is a recombinant protein expressed from E.coli. Its predicted molecular weight is 62.7 kDa. The purity is>90% (SDS-PAGE).
Specifications
Target Information
The hemagglutinin (H9) of influenza A virus is a major surface protein of the H9 subtype, which is enzootic in Asia, the Middle East, and parts of Africa, causing significant economic losses to the poultry industry. In veterinary medicine, the H9 hemagglutinin is a key target for vaccine development, as it can induce neutralizing antibodies that protect animals from infection. It is also used in diagnostic tests to detect antibodies in serum, indicating infection. The stability and receptor-binding properties of H9 hemagglutinin influence viral transmission and pathogenicity, which are important for understanding the virus's epidemiology and zoonotic potential.
Shipping and Storage
This product is shipped with ice packs. Lyophilized protein can be stored at -20°C for 1 year. After reconstitution, the protein solution can be stored at 2-8°C for 2-7 days.
Documents
The product is for research use only.
Not for commercial, prophylactic, diagnostic, or therapeutic applications.
User Note
- Always centrifuge tubes before opening. Avoid mixing by vortexing or pipetting. Aliquot the reconstituted solution to minimize freeze-thaw cycles.